ANAPC1 and SLCO3A1 are associated with nicotine dependence: Meta-analysis of genome-wide association studies

Drug and Alcohol Dependence

Volumn 124, Issue 3, 2012, Pages 325-332

  Wang, Ke Sheng ^a   Liu, Xuefeng ^a   Zhang, Qunyuan ^b   Zeng, Min ^a  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

ANAPC1; Genome wide association; Meta analysis; Nicotine dependence; SLCO3A1

Indexed keywords

ADULT; AGED; ANAPC1 GENE; ARTICLE; AUSTRALIA; CAUCASIAN; CHROMOSOME 15Q; CHROMOSOME 2Q; CONTROLLED STUDY; FEMALE; GENE; GENE LOCATION; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KANK1 GENE; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NCAM1 GENE; PRIORITY JOURNAL; REPLICATION STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SLCO3A1 GENE; TCC12 GENE; TOBACCO DEPENDENCE; ZCCHC14 GENE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MIDDLE AGED; ORGANIC ANION TRANSPORTERS; POLYMORPHISM, SINGLE NUCLEOTIDE; TOBACCO USE DISORDER; UBIQUITIN-PROTEIN LIGASE COMPLEXES;

EID: 84863991135     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2012.02.003     Document Type: Article

References (63)

1. Allen-Brady K., Miller J., Matsunami N., Stevens J., Block H., Farley M., Krasny L., Pingree C., Lainhart J., Leppert M., McMahon W.M., Coon H. A high-density SNP genome-wide linkage scan in a large autism extended pedigree. Mol. Psychiatry 2009, 14:590-600.
2. Amos C.I., Wu X., Broderick P., Gorlov I.P., Gu J., Eisen T., Dong Q., Zhang Q., Gu X., Vijayakrishnan J., Sullivan K., Matakidou A., Wang Y., Mills G., Doheny K., Tsai Y.Y., Chen W.V., Shete S., Spitz M.R., Houlston R.S. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat. Genet. 2008, 40:616-622.
3. Atz M.E., Rollins B., Vawter M.P. NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences. Psychiatr. Genet. 2007, 17:55-67.
4. Benowitz N.L. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu. Rev. Pharmacol. Toxicol. 2009, 49:57-71.
5. Bierut L.J. Genetic vulnerability and susceptibility to substance dependence. Neuron 2011, 69:618-627.
6. Bierut L.J., Agrawal A., Bucholz K.K., Doheny K.F., Laurie C., Pugh E., Fisher S., Fox L., Howells W., Bertelsen S., Hinrichs A.L., Almasy L., Breslau N., Culverhouse R.C., Dick D.M., Edenberg H.J., Foroud T., Grucza R.A., Hatsukami D., Hesselbrock V., Johnson E.O., Kramer J., Krueger R.F., Kuperman S., Lynskey M., Mann K., Neuman R.J., Nöthen M.M., Nurnberger J.I., Porjesz B., Ridinger M., Saccone N.L., Saccone S.F., Schuckit M.A., Tischfield J.A., Wang J.C., Rietschel M., Goate A.M., Rice J.P., Gene, Environment Association Studies Consortium A genome-wide association study of alcohol dependence. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5082-5087.
7. Bierut L.J., Dinwiddie S.H., Begleiter H., Crowe R.R., Hesselbrock V., Nurnberger J.I., Porjesz B., Schuckit M.A., Reich T. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch. Gen. Psychiatry 1998, 55:982-988.
8. Bierut L.J., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O.F., Swan G.E., Rutter J., Bertelsen S., Fox L., Fugman D., Goate A.M., Hinrichs A.L., Konvicka K., Martin N.G., Montgomery G.W., Saccone N.L., Saccone S.F., Wang J.C., Chase G.A., Rice J.P., Ballinger D.G. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum. Mol. Genet. 2007, 16:24-35.
9. Caporaso N., Gu F., Chatterjee N., Sheng-Chih J., Yu K., Yeager M., Chen C., Jacobs K., Wheeler W., Landi M.T., Ziegler R.G., Hunter D.J., Chanock S., Hankinson S., Kraft P., Bergen A.W. Genome-wide and candidate gene association study of cigarette smoking behaviors. PLoS One 2009, 4:e4653.
10. de Leon J., Becona E., Gurpegui M., Gonzalez-Pinto A., Diaz F.J. The association between high nicotine dependence and severe mental illness may be consistent across countries. J. Clin. Psychiatry 2002, 63:812-816.
11. Ducci F., Kaakinen M., Pouta A., Hartikainen A.L., Veijola J., Isohanni M., Charoen P., Coin L., Hoggart C., Ekelund J., Peltonen L., Freimer N., Elliott P., Schumann G., Järvelin M.R. TTC12-ANKK1-DRD2 and CHRNA5-CHRNA3-CHRNB4 influence different pathways leading to smoking behavior from adolescence to mid-adulthood. Biol. Psychiatry 2011, 69:650-660.
12. Dudbridge F., Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet. Epidemiol. 2008, 32:227-234.
13. Gelernter J., Yu Y., Weiss R., Brady K., Panhuysen C., Yang B.Z., Kranzler H.R., Farrer L. Haplotype spanning TTC12 and ANKK1, flanked by the DRD2 and NCAM1 loci, is strongly associated to nicotine dependence in two distinct American populations. Hum. Mol. Genet. 2006, 15:3498-3507.
14. Grant B.F., Hasin D.S., Chou S.P., Stinson F.S., Dawson D.A. Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch. Gen. Psychiatry 2004, 61:1107-1115.
15. Grant J.D., Agrawal A., Bucholz K.K., Madden P.A., Pergadia M.L., Nelson E.C., Lynskey M.T., Todd R.D., Todorov A.A., Hansell N.K., Whitfield J.B., Martin N.G., Heath A.C. Alcohol consumption indices of genetic risk for alcohol dependence. Biol. Psychiatry 2009, 66:795-800.
16. Hatchell P.C., Collins A.C. The influence of genotype and sex on behavioral sensitivity to nicotine in mice. Psychopharmacology (Berl.) 1980, 71:45-49.
17. He M.L., Chen Y., Chen Q., He Y., Zhao J., Wang J., Yang H., Kung H.F. Multiple gene dysfunctions lead to high cancer-susceptibility: evidences from a whole-exome sequencing study. Am. J. Cancer Res. 2011, 1:562-573.
18. Hinrichs A.L., Murphy S.E., Wang J.C., Saccone S., Saccone N., Steinbach J.H., Goate A., Stevens V.L., Bierut L.J. Common polymorphisms in FMO1 are associated with nicotine dependence. Pharmacogenet. Genomics 2011, (Epub ahead of print) 2011 Apr 30.
19. Hoffmann T., Lange C. P2BAT: a massive parallel implementation of PBAT for genome-wide association studies in R. Bioinformatics 2006, 22:3103-3105.
20. Hube R.D., Gao B., Sidler Pfändler M.A., Zhang-Fu W., Leuthold S., Hagenbuch B., Folkers G., Meier P.J., Stieger B. Characterization of two splice variants of human organic anion transporting polypeptide 3A1 isolated from human brain. Am. J. Physiol. Cell Physiol. 2007, 292:C795-C806.
21. Hung R.J., McKay J.D., Gaborieau V., Boffetta P., Hashibe M., Zaridze D., Mukeria A., Szeszenia-Dabrowska N., Lissowska J., Rudnai P., Fabianova E., Mates D., Bencko V., Foretova L., Janout V., Chen C., Goodman G., Field J.K., Liloglou T., Xinarianos G., Cassidy A., McLaughlin J., Liu G., Narod S., Krokan H.E., Skorpen F., Elvestad M.B., Hveem K., Vatten L., Linseisen J., Clavel-Chapelon F., Vineis P., Bueno-de-Mesquita H.B., Lund E., Martinez C., Bingham S., Rasmuson T., Hainaut P., Riboli E., Ahrens W., Benhamou S., Lagiou P., Trichopoulos D., Holcatova I., Merletti F., Kjaerheim K., Agudo A., Macfarlane G., Talamini R., Simonato L., Lowry R., Conway D.I., Znaor A., Healy C., Zelenika D., Boland A., Delepine M., Foglio M., Lechner D., Matsuda F., Blanche H., Gut I., Heath S., Lathrop M., Brennan P. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008, 452:633-637.
22. Jorgensen P.M., Graslund S., Betz R., Stahl S., Larsson C., Hoog C. Characterisation of the human APC1, the largest subunit of the anaphase-promoting complex. Gene 2001, 262:51-59.
23. Kalman D., Morissette S.B., George T.P. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am. J. Addict. 2005, 14:106-123.
24. Kim J.M., Sohn H.Y., Yoon S.Y., Oh J.H., Yang J.O., Kim J.H., Song K.S., Rho S.M., Yoo H.S., Kim Y.S., Kim J.G., Kim N.S. Identification of gastric cancer-related genes using a cDNA microarray containing novel expressed sequence tags expressed in gastric cancer cells. Clin. Cancer Res. 2005, 11:473-482.
25. Kranzler H.R., Gelernter J., Panhuysen C., Weiss R., Brady K., Poling J., Krauthammer M., Farrer L., Kranzler H.R. Genomewide linkage scan for nicotine dependence and identification of a novel chromosome 5 risk locus. Biol. Psychiatry 2007, 61:119-126.
26. Lessov C.N., Martin N.G., Statham D.J., Todorov A.A., Slutske W.S., Bucholz K.K., Madden P.A. Defining nicotine dependence for genetic research: evidence for Australian twins. Psychol. Med. 2004, 34:865-879.
27. Lessov-Schlaggar C.N., Pergadia M.L., Khroyan T.V., Swan G.E. Genetics of nicotine dependence and pharmacotherapy. Biochem. Pharmacol. 2008, 75:178-195.
28. Li M.D., Beuten J., Ma J.Z., Payne T.J., Lou X.Y., Garcia V., Duenes A.S., Crews K.M., Elston R.C. Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. Hum. Mol. Genet. 2005, 14:1211-1219.
29. Li M.D., Cheng R., Ma J.Z., Swan G.E. A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction 2003, 98:23-31.
30. Li M.D. The genetics of nicotine dependence. Curr. Psychiatry Rep. 2006, 8:158-164.
31. Lind P.A., Macgregor S., Vink J.M., Pergadia M.L., Hansell N.K., de Moor M.H., Smit A.B., Hottenga J.J., Richter M.M., Heath A.C., Martin N.G., Willemsen G., de Geus E.J., Vogelzangs N., Penninx B.W., Whitfield J.B., Montgomery G.W., Boomsma D.I., Madden P.A. A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. Twin Res. Hum. Genet. 2010, 13:10-29.
32. Liu X., Cheng R., Verbitsky M., Kisselev S., Browne A., Mejia-Sanatana H., Louis E.D., Cote L.J., Andrews H., Waters C., Ford B., Frucht S., Fahn S., Marder K., Clark L.N., Lee J.H. Genome-wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population. BMC Med Genet. 2011, 12:104.
33. Liu Y.Z., Pei Y.F., Guo Y.F., Wang L., Liu X.G., Yan H., Xiong D.H., Zhang Y.P., Levy S., Li J., Haddock C.K., Papasian C.J., Xu Q., Ma J.Z., Payne T.J., Recker R.R., Li M.D., Deng H.W. Genome-wide association analyses suggested a novel mechanism for smoking behavior regulated by IL15. Mol. Psychiatry 2009, 14:668-680.
34. Liu J.Z., Tozzi F., Waterworth D.M., Pillai S.G., Muglia P., Middleton L., Berrettini W., Knouff C.W., Yuan X., Waeber G., Vollenweider P., Preisig M., Wareham N.J., Zhao J.H., Loos R.J., Barroso I., Khaw K.T., Grundy S., Barter P., Mahley R., Kesaniemi A., McPherson R., Vincent J.B., Strauss J., Kennedy J.L., Farmer A., McGuffin P., Day R., Matthews K., Bakke P., Gulsvik A., Lucae S., Ising M., Brueckl T., Horstmann S., Wichmann H.E., Rawal R., Dahmen N., Lamina C., Polasek O., Zgaga L., Huffman J., Campbell S., Kooner J., Chambers J.C., Burnett M.S., Devaney J.M., Pichard A.D., Kent K.M., Satler L., Lindsay J.M., Waksman R., Epstein S., Wilson J.F., Wild S.H., Campbell H., Vitart V., Reilly M.P., Li M., Qu L., Wilensky R., Matthai W., Hakonarson H.H., Rader D.J., Franke A., Wittig M., Schäfer A., Uda M., Terracciano A., Xiao X., Busonero F., Scheet P., Schlessinger D., St Clair D., Rujescu D., Abecasis G.R., Grabe H.J., Teumer A., Völzke H., Petersmann A., John U., Rudan I., Hayward C., Wright A.F., Kolcic I., Wright B.J., Thompson J.R., Balmforth A.J., Hall A.S., Samani N.J., Anderson C.A., Ahmad T., Mathew C.G., Parkes M., Satsangi J., Caulfield M., Munroe P.B., Farrall M., Dominiczak A., Worthington J., Thomson W., Eyre S., Barton A., Wellcome Trust Case Control Consortium, Mooser V., Francks C., Marchini J. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat. Genet. 2010, 42:436-440.
35. Lou X.Y., Ma J.Z., Sun D., Payne T.J., Li M.D. Fine mapping of a linkage region on chromosome 17p13 reveals that GABARAP and DLG4 are associated with vulnerability to nicotine dependence in European-Americans. Hum. Mol. Genet. 2007, 16:142-153.
36. Ma J.Z., Beuten J., Payne T.J., Dupont R.T., Elston R.C., Li M.D. Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. Hum. Mol. Genet. 2005, 14:1691-1698.
37. Maes H.H., Sullivan P.F., Bulik C.M., Neale M.C., Prescott C.A., Eaves L.J., Kendler K.S. A twin study of genetic and environmental influences on tobacco initiation, regular tobacco use and nicotine dependence. Psychol. Med. 2004, 34:1251-1261.
38. Medves S., Duhoux F.P., Ferrant A., Toffalini F., Ameye G., Libouton J.M., Poirel H.A., Demoulin J.B. KANK1, a candidate tumor suppressor gene, is fused to PDGFRB in an imatinib-responsive myeloid neoplasm with severe thrombocythemia. Leukemia 2010, 24:1052-1055.
39. Montasser M.E., Shimmin L.C., Hanis C.L., Boerwinkle E., Hixson J.E. Gene by smoking interaction in hypertension: identification of a major quantitative trait locus on chromosome 15q for systolic blood pressure in Mexican-Americans. J. Hypertens. 2009, 27:491-501.
40. Nelson E.C., Heath A.C., Bucholz K.K., Madden P.A., Fu Q., Knopik V., Lynskey M.T., Lynskey M.T., Whitfield J.B., Statham D.J., Martin N.G. Genetic epidemiology of alcohol-induced blackouts. Arch. Gen. Psychiatry 2004, 61:257-263.
41. Pillai S.G., Ge D., Zhu G., Kong X., Shianna K.V., Need A.C., Feng S., Hersh C.P., Bakke P., Gulsvik A., Ruppert A., Lødrup Carlsen K.C., Roses A., Anderson W., Rennard S.I., Lomas D.A., Silverman E.K., Goldstein D.B., ICGN Investigators A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009, 5:e1000421.
42. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
43. Purcell S., Neale B., Todd-Brown K., Thomas L., Ferreira M.A., Bender D., Maller J., Sklar P., de Bakker P.I., Daly M.J., Sham P.C. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 2007, 81:559-575.
44. Robinson S.F., Marks M.J., Collins A.C. Inbred mouse strains vary in oral self-selection of nicotine. Psychopharmacology (Berl.) 1996, 124:332-339.
45. Saccone S.F., Hinrichs A.L., Saccone N.L., Chase G.A., Konvicka K., Madden P.A., Breslau N., Johnson E.O., Hatsukami D., Pomerleau O., Swan G.E., Goate A.M., Rutter J., Bertelsen S., Fox L., Fugman D., Martin N.G., Montgomery G.W., Wang J.C., Ballinger D.G., Rice J.P., Bierut L.J. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum. Mol. Genet. 2007, 16:36-49.
46. Saccone N.L., Culverhouse R.C., Schwantes-An T.H., Cannon D.S., Chen X., Cichon S., Giegling I., Han S., Han Y., Keskitalo-Vuokko K., Kong X., Landi M.T., Ma J.Z., Short S.E., Stephens S.H., Stevens V.L., Sun L., Wang Y., Wenzlaff A.S., Aggen S.H., Breslau N., Broderick P., Chatterjee N., Chen J., Heath A.C., Heliövaara M., Hoft N.R., Hunter D.J., Jensen M.K., Martin N.G., Montgomery G.W., Niu T., Payne T.J., Peltonen L., Pergadia M.L., Rice J.P., Sherva R., Spitz M.R., Sun J., Wang J.C., Weiss R.B., Wheeler W., Witt S.H., Yang B.Z., Caporaso N.E., Ehringer M.A., Eisen T., Gapstur S.M., Gelernter J., Houlston R., Kaprio J., Kendler K.S., Kraft P., Leppert M.F., Li M.D., Madden P.A., Nöthen M.M., Pillai S., Rietschel M., Rujescu D., Schwartz A., Amos C.I., Bierut L.J. Multiple independent loci at chromosome 15q25.1 affect smoking quantity: a meta-analysis and comparison with lung cancer and COPD. PLoS Gene 2010, 6:6.
47. Sarkar S., Roy B.C., Hatano N., Aoyagi T., Gohji K., Kiyama R. A novel ankyrin repeat-containing gene (Kank) located at 9p24 is a growth suppressor of renal cell carcinoma. J. Biol. Chem. 2002, 277:36585-36591.
48. Singhal S., Amin K.M., Kruklitis R., DeLong P., Friscia M.E., Litzky L.A., Putt M.E., Kaiser L.R., Albelda S.M. Alterations in cell cycle genes in early stage lung adenocarcinoma identified by expression profiling. Cancer Biol. Ther. 2003, 2:291-298.
49. Sullivan P.F., Keefe R.S., Lange L.A., Lange E.M., Stroup T.S., Lieberman J., Maness P.F. NCAM1 and neurocognition in schizophrenia. Biol. Psychiatry 2007, 61:902-910.
50. Sullivan P.F., Kendler K.S. The genetic epidemiology of smoking. Nicotine Tob. Res. 1999, 1(Suppl. 2):S51-S57.
51. Thorgeirsson T.E., Geller F., Sulem P., Rafnar T., Wiste A., Magnusson K.P., Manolescu A., Thorleifsson G., Stefansson H., Ingason A., Stacey S.N., Bergthorsson J.T., Thorlacius S., Gudmundsson J., Jonsson T., Jakobsdottir M., Saemundsdottir J., Olafsdottir O., Gudmundsson L.J., Bjornsdottir G., Kristjansson K., Skuladottir H., Isaksson H.J., Gudbjartsson T., Jones G.T., Mueller T., Gottsäter A., Flex A., Aben K.K., de Vegt F., Mulders P.F., Isla D., Vidal M.J., Asin L., Saez B., Murillo L., Blondal T., Kolbeinsson H., Stefansson J.G., Hansdottir I., Runarsdottir V., Pola R., Lindblad B., van Rij A.M., Dieplinger B., Haltmayer M., Mayordomo J.I., Kiemeney L.A., Matthiasson S.E., Oskarsson H., Tyrfingsson T., Gudbjartsson D.F., Gulcher J.R., Jonsson S., Thorsteinsdottir U., Kong A., Stefansson K. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008, 452:638-642.
52. Tobacco and Genetics (TAG) Consortium Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet. 2010, 42:441-447.
53. Vazza G., Bertolin C., Scudellaro E., Vettori A., Boaretto F., Rampinelli S., De Sanctis G., Perini G., Peruzzi P., Mostacciuolo M.L. Genome-wide scan supports the existence of a susceptibility locus for schizophrenia and bipolar disorder on chromosome 15q26. Mol. Psychiatry 2007, 12:87-93.
54. Volpi S., Heaton C., Mack K., Hamilton J.B., Lannan R., Wolfgang C.D., Licamele L., Polymeropoulos M.H., Lavedan C. Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia. Mol. Psychiatry 2009, 14:1024-1031.
55. Wang C.X., Fisk B.C., Wadehra M., Su H., Braun J. Overexpression of murine fizzy-related (fzr) increases natural killer cell-mediated cell death and suppresses tumor growth. Blood 2000, 96:259-263.
56. Wang Q., Moyret-Lalle C., Couzon F., Surbiguet-Clippe C., Saurin J.C., Lorca T., Navarro C., Puisieux A. Alterations of anaphase-promoting complex genes in human colon cancer cells. Oncogene 2003, 22:1486-1490.
57. Wäsch R., Robbins J.A., Cross F.R. The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression. Oncogene 2010, 29:1-10.
58. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678.
59. WHO, 2005. The World Health Report.
60. Yang B.Z., Kranzler H.R., Zhao H., Gruen J.R., Luo X., Gelernter J. Association of haplotypic variants in DRD2, ANKK1, TTC12 and NCAM1 to alcohol dependence in independent case control and family samples. Hum. Mol. Genet. 2007, 16:2844-2853.
61. Yang B.Z., Kranzler H.R., Zhao H., Gruen J.R., Luo X., Gelernter J. Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence. Alcohol. Clin. Exp. Res. 2008, 32:2117-2127.
62. Yang Y., Kim A.H., Yamada T., Wu B., Bilimoria P.M., Ikeuchi Y., de la Iglesia N., Shen J., Bonni A. A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science 2009, 326:575-578.
63. Zhang X.Y., Xiu M.H., Chen da C., Yang F.D., Wu G.Y., Lu L., Kosten T.A., Kosten T.R. Nicotine dependence and serum BDNF levels in male patients with schizophrenia. Psychopharmacology (Berl.) 2010, 212:301-307.